Coronary Stents Market Size, Share and Growth Forecast 2025-2033

[Rohit Pujari]

Market Overview:

The coronary stents market is experiencing rapid growth, driven by Rising Cardiovascular Disease Burden, Technological Advancements in Stent Design, and Growing Preference for Minimally Invasive Procedures. According to IMARC Group's latest research publication, "Coronary Stents Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025–2033", The global coronary stents market size reached USD 11.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.18% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Download a sample PDF of this report: https://www.imarcgroup.com/coronary-stents-market/requestsample

Our Report Includes:

• Market Dynamics
• Market Trends and Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Coronary Stents Market:

• Rising Cardiovascular Disease Burden

Coronary artery disease is the most common cause of death in humans and, therefore, coronary stents are playing an increasing role in positive heart disease treatment. Over 17 million people die of cardiovascular disease each year. Most health systems now focus on early intervention for these blocked arteries to improve blood flow particularly in the high-risk population. Stents play a major role in solving the problem. In the United States, India and China, awareness of coronary artery disease has increased and this has led to an increased demand for PCI. Public health initiatives, screening programs across the globe and patient stories on social media have also contributed to this. This is one of the factors which are making coronary stents a necessity in the modern cardiac care unit.

• Technological Advancements in Stent Design

The market is changing with investments in stent materials and the drug delivery system (DES has become ubiquitous based on major clinical reductions in restenosis rates). Other technology investments are in thinner struts, more durable and biodegradable polymers, and bioabsorbable scaffolds made by Abbot, Boston Scientific, Medtronic, and others. According to one study done by LinkedIn, the medical expos for the next-gen stents are more likely to treat complex lesion or diabetics. Also, the new generation of the DES is rapidly adopted in the developed market. In the emerging DES market, the wider availability of such access through industry cooperatives and pricing programs is taking patient and stent success and safety in interventional cardiology to a new level.

• Growing Preference for Minimally Invasive Procedures

The trend to less intrusive therapy has led to increasing utilization of coronary stents. Angioplasty with a stent is less expensive and has a lower risk to the patient, a lower risk of complication and a shorter recovery time when compared with open heart surgery of equivalent effectiveness. Self expandables are being used more often in emergency and non emergency environments. A similar pattern is also happening in Asia and in Latin America as people gain experience in easier ways to find healthcare. Social media is a major source of information for physicians. Popular doctors on social networking sites like X (formerly Twitter) and Facebook promote less intrusive heart surgeries for CAD, the leading indication for coronary stenting. This increase is also due to more hospitals opening catheterization laboratories.

Key Trends in the Coronary Stents Market:

• Adoption of Bioabsorbable Stents

Bioabsorbable stent is a core cardiovascular intervention platform that temporarily holds blocked arteries open during treatment and dissolves later to prevent stent-related complications downstream. Companies like BIOTRONIK and Abbott are mentioned in various posts about stent technology in social media, webinars and clinical articles documenting the success and advantages of clinical trials and proof of innovative cardiovascular devices. They are considered leaders in magnesium based and polymeric resolute stent technology in Europe and Japan where regulatory constraint is less prohibitive of innovation with respect to technology and design. Future developments may include less permanent stenting and the use of bioabsorbable stents in the stenting armamentarium.

• Use of Advanced Imaging and Navigation Technologies

The increasing use of high resolution techniques such as intravascular ultrasound (IVUS) and Optical coherence tomography (OCT) could allow for more accurate stent placement. These techniques are already used by interventional cardiologists to analyze vessel anatomy, confirm stent position, and place the stent. The earliest adoption can be found in North America and Western Europe where reimbursement existed for IVUS/OCT, alongside training programs. The use of IVUS and OCT examples are available by specialist estimates on professional social networking sites such as LinkedIn. This trend is pushing the demand for highly developed stent products.

• Increased Access to Healthcare in Emerging Economies

Further, the rapid expansion of the health care infrastructure in developing countries, the fact that coronary stenting is now being performed in developing country hospitals, and the availability of public private partnership with government-backed insurance schemes, have made the stent affordable and available in second and third level towns. Government-backed health insurance schemes like India's Ayushman Bharat, and Brazil's SUS system, have also globalized cardiovascular interventional procedures. Global health organizations have been advertising new cardiology cath labs and cardiology fellowships on LinkedIn which will impact Asia-Pacific, Latin America and Africa's stent market growth rate during the forecast period substantially.

Leading Companies Operating in the Global Coronary Stents Industry:

• Abbott Laboratories
• B. Braun Melsungen AG
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Elixir Medical Corporation
• Lepu Medical Technology (Beijing) Co. Ltd.
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• Terumo Corporation
• Translumina GmbH.

Coronary Stents Market Report Segmentation:

By Type:

• Drug-eluting Stents
• Bare-metal Coronary Stents
• Bioabsorbable Stents

Drug-eluting stents represent the largest segment due to their superior clinical outcomes compared to other types of stents.

By Biomaterial:

• Metallic Biomaterial
• Polymeric Biomaterial
• Natural Biomaterial

Metallic biomaterial accounts for the majority of the market share owing to its exceptional mechanical properties, biocompatibility, and proven clinical efficacy.

By Mode of Delivery:

• Balloon-expandable Stents
• Self-expanding Stents

Self-expanding stents hold the biggest market share as their flexibility and ability to conform to the natural contours of the blood vessels make them particularly effective in treating complex lesions and tortuous anatomies.

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

Hospitals exhibit a clear dominance in the market, driven by comprehensive care provided by them, including preoperative, perioperative, and postoperative management.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position in the coronary stents market on account of a high prevalence of cardiovascular diseases.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sa...@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1–201971–6302